The Latest in Conference Coverage

Can MS be stopped early in its tracks?

October 31, 2022

Multiple Sclerosis

Is MRI a viable alternative to lumbar puncture for MS diagnosis?

October 31, 2022

Multiple Sclerosis

NfL levels might presage MS disability

October 31, 2022

Multiple Sclerosis

A better way to predict fall risk in patients with MS?

October 28, 2022

Multiple Sclerosis

‘Reassuring data’ for two MS meds in pregnancy

October 28, 2022

Multiple Sclerosis

Should McDonald criteria include optical nerve lesions?

October 28, 2022

Multiple Sclerosis

Stem cell transplantation ‘substantially’ superior to fingolimod in cutting MS relapse risk

October 28, 2022

Multiple Sclerosis

Higher cardiovascular fitness may help preserve mobility in MS

October 27, 2022

Multiple Sclerosis

High-efficacy therapies for MS: When and how to use them

October 27, 2022

Multiple Sclerosis

Cognitive impairment may predict physical disability in MS

July 11, 2022

Multiple Sclerosis

Risk of drug interactions is on the rise as MS drugs evolve

June 13, 2022

Multiple Sclerosis

Consider the wider picture in relapsing remitting MS

June 13, 2022

Multiple Sclerosis

Inebilizumab beneficial across genotypes in NMOSD

June 10, 2022

Multiple Sclerosis

Stem cell transplants for MS are a ‘reasonable option,’ but questions persist

June 7, 2022

Multiple Sclerosis

MS and COVID-19: Conflicting signs on risk but some trends are clearer

June 7, 2022

Multiple Sclerosis